CME vs ECL · P/E 22, rev $6.52B vs P/E 35, rev $4.01B
CME Group Inc (CME) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
CME currently screens at market cap $91.25B and trailing P/E 21.9. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the CME and ECL stock pages for the full models.
Not investment advice.